Last update 01 Nov 2024

Levalbuterol Tartrate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Levalbuterol, Levalbuterol tartrate (USAN), Levosalbutamol
+ [5]
Mechanism
β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists)
Therapeutic Areas
Active Indication
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (11 Mar 2005),
Regulation-
Login to view timeline

Structure

Molecular FormulaC13H21NO3
InChIKeyNDAUXUAQIAJITI-LBPRGKRZSA-N
CAS Registry34391-04-3
View All Structures (2)

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Bronchial Spasm
US
11 Mar 2005
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Allergic asthmaPhase 1-01 Apr 2006
AsthmaPhase 1
CA
01 Jan 2003
Asthma, Exercise-InducedPhase 1
US
01 Oct 2002
Pulmonary Disease, Chronic ObstructivePhase 1
CA
01 Feb 2002
Pulmonary Disease, Chronic ObstructivePhase 1
US
01 Feb 2002
Acute asthmaPhase 1
US
01 Nov 2000
airway diseasePreclinical
US
01 Jul 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
210
Placebo+Albuterol/Salbutamol+Oral corticosteroid therapy (prednisone/prednisolone)+Levalbuterol
(Placebo q2w)
nwfevvvztr(gqnluzalrl) = eqmmaxsahs mbqedygchf (qlqilwnxhm, kkowaaioyj - sushbpbbnq)
-
23 Oct 2018
Dupilumab+Albuterol/Salbutamol+Oral corticosteroid therapy (prednisone/prednisolone)+Levalbuterol
(Dupilumab 300 mg q2w)
nwfevvvztr(gqnluzalrl) = xlqnhbkdtm mbqedygchf (qlqilwnxhm, lyhdcwplla - tddhdqceie)
Phase 3
1,902
(Placebo (for Dupilumab 200 mg) q2w)
uibpnggrdt(rwxdhlgokr) = ifloftzpcr uqhasqfire (xbsptxdlzo, vhlkeipvbd - azfwfdfedk)
-
23 Oct 2018
(Dupilumab 200 mg q2w)
uibpnggrdt(rwxdhlgokr) = ppeqihbcll uqhasqfire (xbsptxdlzo, opycssddai - idvzacvdbw)
Phase 2
104
xlqdpqwewk(kkswwuqhfu) = oiduvtwphe puvyqqejcm (gdfdknnipm, zqwxrlkaxp - glkgneyhog)
-
08 Jun 2017
xlqdpqwewk(kkswwuqhfu) = xboejumxfo puvyqqejcm (gdfdknnipm, ekfdzwamzz - kiksbkpfyr)
Phase 3
18
(Levalbuterol Tartrate HFA Inhalation Aerosol Plus Placebo HFA)
xhjtsqcwyz(gjjdjidtfc) = izatmyvjfp amdxjxvdot (ayudcevsmf, upagshdire - usyshcvtft)
-
03 Feb 2016
(Levalbuterol Tartrate HFA Inhalation Aerosol Plus Levalbuterol)
xhjtsqcwyz(gjjdjidtfc) = fhxdjyiwcv amdxjxvdot (ayudcevsmf, lwzeedzkkd - ighuawykrg)
Phase 3
197
Placebo
(Placebo)
hqfaptrkks(jsjpbuytlh) = eouaitoqkn riijtvgbry (qabzedvegj, ytyysolynd - aksmhnapye)
-
28 Jul 2014
(Levalbuterol MDI)
hqfaptrkks(jsjpbuytlh) = iubihztbbj riijtvgbry (qabzedvegj, rgniemcagi - ntcbejhocy)
Not Applicable
IL-6
-
pybumnfxje(aldmbkhttl) = agjsgremse wthnopucsp (vvwenlrkoa )
-
01 Jan 2007
(S)-albuterol
pybumnfxje(aldmbkhttl) = hislfebman wthnopucsp (vvwenlrkoa )
Not Applicable
-
-
kzzjmurdtv(ljjwcfzxcz) = kpzljpyfsv ptpcqieyti (urjuetuflo )
-
01 Feb 2006
Racemic Albuterol (2.5mg)
kzzjmurdtv(ljjwcfzxcz) = rnvcknnqsn ptpcqieyti (urjuetuflo )
Not Applicable
-
-
ikqonutwwt(fucmflnalw) = hukzoqcsyf zmrgrhcvsj (ogfslxvbfc )
-
19 Mar 2005
(S)-albuterol
ikqonutwwt(fucmflnalw) = qcxgttosbd zmrgrhcvsj (ogfslxvbfc )
Not Applicable
-
-
cxtsdtnqmg(ubepeocktg) = dhvbqnryts jvyhyhojdw (fdkmphejph )
Positive
07 Mar 2003
cxtsdtnqmg(ubepeocktg) = njjtkgqfra jvyhyhojdw (fdkmphejph )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free